Some of the more than a dozen states that cover GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid are scrambling ...

Studies show that GLP-1 agonists can help patients lose 5-15% of their body weight when combined with diet and exercise.

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are ...

Expanding obesity treatment access could generate $10 trillion for the country by boosting productivity, cutting healthcare ...

President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the ...

WE'VE heard celebrities talk about the positives of Ozempic and other fat loss jabs ... and that doesn't include private prescriptions that cost £200 a month. Many have called it a 'miracle ...

They’re both prescribed for adults with type 2 diabetes who may or may not have certain cardiovascular problems. Each drug is also approved for other uses. The active ingredient in Ozempic is ...

Ozempic has gained popularity for its role in controlling blood sugar. But while it can support weight loss efforts, it’s only prescribed for type 2 diabetes. So, many people look for substitutes ...

There are a number of famous faces in the UK who've tried Ozempic and other appetite-suppressing drugs in the hopes of losing some weight. Among their number is Jeremy Clarkson, who recently wrote how ...

The rising cost of weight loss drugs has prompted many ... While there has been no shortage of Ozempic-related scams, a new study is exploring other risks consumers face when ordering weight ...

Srinivas seemed to be responding, in part, to a user theory that the company is “doing horribly financially” and “making lots of changes to cut costs.” As an example, the theorizer pointed ...